Good morning :)
$
AdvisorShares Psychedelics ETF

AdvisorShares Psychedelics ETF

PSIL

NYSE ARCA
$25.060.84% (+0.20)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

US ETF

Miscellaneous Sector

Sectoral & Thematic ETF

Invests in miscellaneous sectors

Key Metrics

Key Metrics

Expense Ratio
Expense Ratio

The operating and administrative costs of running the fund measured as the percentage of fund assets

0.99%
AUM
AUM

Current market value of the ETF scheme managed by the Asset Management Company

$58.27M
Beta
Beta

Sensitivity of the stock's price relative to the country's key indices over the last 5 years

0.42
Volatility (3Y)
Volatility (3Y)

The annualized standard deviation of the ETF's returns calculated over the last 3 years

45.03%
PE
PE

Ratio of price to the prospective earnings of the ETF's underlyings

23.60
PE Category
PE Category

Ratio of price to the prospective earnings of the holdings of ETFs from the same category

18.08

ETF Profile

Peers

Peers

Exp. Ratio
0.2%
0.2%
PE
19.06
19.06
1Y Return
8.59%
8.59%
Exp. Ratio
0.41%
0.41%
PE
18.07
18.07
1Y Return
15.85%
15.85%
Exp. Ratio
0.83%
0.83%
PE
227.01
227.01
1Y Return
12.52%
12.52%
Exp. Ratio
0.67%
0.67%
PE
15.22
15.22
1Y Return
6.42%
6.42%
Exp. Ratio
0.85%
0.85%
PE
19.35
19.35
1Y Return
5.64%
5.64%

Peers & Comparison

Peers & Comparison

Comparing 2 ETFs from
ETFMiscellaneous Sector
ETFTotal AUMTotal AUMExp. RatioExp. Ratio1Y Return1Y Return
AdvisorShares Psychedelics ETF $58.27M0.99%41.41%
SPDR Kensho New Economies Composite$2.66B0.2%8.59%
iShares Global Clean Energy ETF$2.09B0.41%15.85%

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Top Holdings

Top Holdings

  • Name
    Holdings
    Sector
  • Compass Pathways Plc
    Sector: Healthcare
    Holdings12.27 %
    Compass Pathways Plc
    CMPS

    Holdings

    12.27 %

    Healthcare
  • Definium Therapeutics, Inc.
    Sector: Healthcare
    Holdings10.57 %
    Definium Therapeutics, Inc.
    DFTX

    Holdings

    10.57 %

    Healthcare
  • Cybin Inc.
    Sector: Healthcare
    Holdings9.11 %
    Cybin Inc.

    Holdings

    9.11 %

    Healthcare
  • Neuronetics Inc
    Sector: Healthcare
    Holdings4.90 %
    Neuronetics Inc
    STIM

    Holdings

    4.90 %

    Healthcare
  • NRX Pharmaceuticals Inc
    Sector: Healthcare
    Holdings4.67 %
    NRX Pharmaceuticals Inc
    NRXP

    Holdings

    4.67 %

    Healthcare
  • GH Research PLC
    Sector: Healthcare
    Holdings4.57 %
    GH Research PLC
    GHRS

    Holdings

    4.57 %

    Healthcare
  • Neurocrine Biosciences Inc
    Sector: Healthcare
    Holdings4.46 %
    Neurocrine Biosciences Inc
    NBIX

    Holdings

    4.46 %

    Healthcare
  • Relmada Therapeutics Inc
    Sector: Healthcare
    Holdings4.45 %
    Relmada Therapeutics Inc
    RLMD

    Holdings

    4.45 %

    Healthcare
  • AbbVie Inc
    Sector: Healthcare
    Holdings4.29 %
    AbbVie Inc
    ABBV

    Holdings

    4.29 %

    Healthcare
  • Alto Neuroscience, Inc.
    Sector: Healthcare
    Holdings4.22 %
    Alto Neuroscience, Inc.
    ANRO

    Holdings

    4.22 %

    Healthcare

Frequently asked questions

  1. AdvisorShares Psychedelics ETF (PSIL) is currently trading at $25.06. You can also track daily change, historical performance, trading volume and other key ETF details on this page.

  2. Indian investors can buy AdvisorShares Psychedelics ETF (PSIL) by opening a US investing account through a platform that provides access to US stocks and ETFs, completing the required verification, transferring funds under the Liberalised Remittance Scheme (LRS), and placing an order in USD.

  3. Yes, Indian residents and NRIs can invest in AdvisorShares Psychedelics ETF (PSIL) through platforms that offer access to US-listed stocks and ETFs, subject to applicable regulations, including RBI’s Liberalised Remittance Scheme (LRS) guidelines.

  4. The expense ratio of AdvisorShares Psychedelics ETF (PSIL) is 0.99%. It represents the annual operating cost charged by the ETF provider for managing the fund and tracking its underlying index.

  5. AdvisorShares Psychedelics ETF (PSIL)’s top holdings currently include Compass Pathways Plc, Definium Therapeutics, Inc., and Cybin Inc.. The ETF’s complete holdings list, allocation and sector exposure are available in the Holdings section on this page.

  6. Many platforms offering US ETF investing allow fractional investing, enabling Indian investors to buy a portion of AdvisorShares Psychedelics ETF (PSIL) instead of a full share. This allows investment based on a fixed dollar amount.

  7. Gains from AdvisorShares Psychedelics ETF (PSIL) are generally taxed in India based on the applicable holding period and tax rules. Dividends may be subject to US withholding tax and Indian taxation rules. The final tax treatment depends on individual circumstances.

  8. Remittances under the Liberalised Remittance Scheme (LRS) for overseas investments, including US ETFs like AdvisorShares Psychedelics ETF (PSIL), may attract TCS above specified thresholds. Applicable rates and limits are determined by government regulations and may change over time.

  9. AdvisorShares Psychedelics ETF (PSIL)’s current assets under management (AUM) are $58.27M. AUM represents the total market value of assets managed by the ETF and indicates the size of the fund.

  10. AdvisorShares Psychedelics ETF (PSIL)’s price-to-earnings (P/E) ratio is 23.60. It represents the weighted valuation of the companies held within the ETF relative to their earnings.

  11. You can compare AdvisorShares Psychedelics ETF (PSIL) with SPDR Kensho New Economies Composite (KOMP), iShares Global Clean Energy ETF (ICLN), and AdvisorShares Pure US Cannabis ETF (MSOS) based on metrics such as expense ratio, AUM, P/E ratio, holdings, liquidity and historical returns in the Peers & Comparison section.

  12. AdvisorShares Psychedelics ETF (PSIL)’s NAV represents the per-unit value of the ETF’s underlying holdings after adjusting for expenses and liabilities. It is calculated once daily after markets close and may differ from the ETF’s live market price.

Loading...